Induction Chemoradiotherapy and Surgical Resection for Selected Stage IIIB Non-Small-Cell Lung Cancer

Annals of Thoracic Surgery

Volumn 76, Issue 6, 2003, Pages 1810-1814

  Ichinose, Yukito ^a   Fukuyama, Yasuro ^a   Asoh, Hiroshi ^a   Ushijima, Chie ^a   Okamoto, Tatsuro ^a   Ikeda, Jiro ^a   Okamoto, Junichi ^a   Sakai, Maki ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; UFT;

ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ESOPHAGITIS; FEMALE; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; LYMPH NODE BIOPSY; MALE; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RASH; STOMACH ULCER; THORACOTOMY; VOMITING;

EID: 0344665499     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)01075-0     Document Type: Article

References (16)

1. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995;311:899-909.
2. Furuse K, Fukuoka M, Kawahara M, et al, for the West Japan Lung Cancer Group. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 1999;17:2692-9.
3. Curran W, Scott C, Langer C, et al. Phase III comparison of sequential vs concurrent chemoradiation for pts with unresected stage III non-small cell lung cancer (NSCLC): report of Radiation Therapy Oncology Group (RTOG) [Abstract]. Proc World Conf Lung Cancer 2000;29:303.
4. Ichinose Y, Yano T, Asoh H, et al. UFT plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer. Oncology 1999;13:98-101.
5. Ichinose Y, Nakai Y, Kudoh S, and the UP-RT Study Group. UFT plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cacner (NSCLC): a multi institutional phase II trial [Abstract]. Proc Am Soc Clin Oncol 2002;21:1280.
6. Albain K, Rusch V, Crowley J, et al. Long-term survival after concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery in bulky, stage IIIA (N2) and IIIB non-small cell lung cancer: 6-year outcomes from Southwest Oncology Group Study 8805 [Abstract]. Proc Am Soc Clin Oncol 1999;18:467.
7. Stamatis G, Eberhardt W, Stüben G, Bildat S, Dahler O, Hillejan L. Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term results. Ann Thorac Surg 1999;68:1144-9.
8. Grunenwald DH, André F, Péchoux CL, et al. Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer. J Thorac Cardiovasc Surg 2001;122:796-802.
9. Rusch VW, Albain KS, Crowley JJ, et al. Neoadjuvant therapy: a novel and effective treatment for stage IIIb non-small cell lung cancer. Ann Thorac Surg 1994;58:290-5.
10. Macchiarini P, Chapelier AR, Monnet I, et al. Extended operations after induction therapy for stage IIIb (T4) non-small cell lung cancer. Ann Thorac Surg 1994;57:966-73.
11. Thomas M, Rübe C, Semik M, et al. Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small-cell lung cancer. J Clin Oncol 1999;17:1185-93.
12. Steinert HC, Hauser M, Alleman F, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997; 202:441-6.
13. Gdeedo A, Van Schil P, Corthouts B, Van Mieghem F, Van Meerbeck J, Van Marck E. Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging. Eur Resp J 1997;10:1547-51.
14. Van Schil PE, Van Hee RH, Schoofs RL. The value of mediastinoscopy in preoperative staging of bronchogenic carcinoma. J Thorac Cardiovasc Surg 1989;97:240-4.
15. Hanson JA, Armstrong P. Radiological evaluation of intrathoracic extension and resectability of non-small cell lung cancer. In: Van Houtte P, Klastersky J, Rocmans P, editors. Progress and perspectives in the treatment of lung cancer. Berlin: Springer, 1999:23-38.
16. Albain KS, Crowley JJ, Turrisi AT, et al. Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019. J Clin Oncol 2002;20:3454-60.